Lowitt Ian T 4

4 · Marex Group plc · Filed Jun 16, 2026

AI-generated summary of this filing

Updated Jun 16, 2026

Marex Group (MRX) CEO Ian Lowitt Sells Shares

What Happened

Ian T. Lowitt, CEO of Marex Group plc (MRX), sold a total of 37,143 ordinary shares on June 12, 2026 in two open-market transactions. He disposed of 32,813 shares at a weighted average price of $62.29 for $2,043,974, and 4,330 shares at a weighted average price of $62.94 for $272,523 — total proceeds approximately $2,316,497. These were sales (not purchases) and therefore generally reflect liquidity rather than a bullish purchase signal.

Key Details

Transaction date: June 12, 2026
Sales: 32,813 shares @ $62.29 (weighted avg; range $61.81–$62.80) and 4,330 shares @ $62.94 (weighted avg; range $62.81–$63.37)
Total shares sold: 37,143; Total proceeds: ~$2,316,497
Plan: Sales were effected pursuant to a Rule 10b5‑1 trading plan entered March 12, 2026 (footnote F1)
Disclosure: Footnotes F2/F3 note the weighted-average prices and that the filer will provide a breakdown of shares sold at each price on request
Ownership note: Filing states it includes 194,411 shares underlying deferred bonus awards previously granted to the reporting person (contingent rights) (footnote F4)
Filing timeliness: Report filed June 16, 2026; this is within the standard two business-day Form 4 filing window for a June 12 trade (not marked late)

Context

These transactions were sales under a pre-established 10b5‑1 plan, which is commonly used to schedule insider trades and is considered routine. The filing is informational — it does not state motives. For retail investors, purchases typically carry more interpretive weight than routine sales; here the disclosure simply records CEO liquidity executed under a trading plan.

Form 4

Period: 2026-06-12

DirectorChief Executive Officer

Transactions

Sale
Ordinary Shares
[F1][F2]
2026-06-12$62.29/sh−32,813$2,043,974→ 2,835,688 total
Sale
Ordinary Shares
[F1][F3][F4]
2026-06-12$62.94/sh−4,330$272,523→ 2,831,358 total

Footnotes (4)

[F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.81 to $62.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.81 to $63.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.

Signature

/s/ Scott Linsley as Attorney-in-Fact, for Ian T. Lowitt|2026-06-16

1 file